Barbari Surrey Sharon's most recent trade in VYNE Therapeutics Inc was a trade of 20,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 1, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| VYNE Therapeutics Inc | Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| VYNE Therapeutics Inc | Surrey-Barbari Sharon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Agile Therapeutics Inc | Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 1,065 | 1,065 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 935 | 974 (0%) | 0% | 0 | Common Stock | |
| VYNE Therapeutics Inc | Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 20,500 | 20,500 | - | - | Stock Options | |
| Agile Therapeutics Inc | Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 807 | 807 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 670 | 1,952 (0%) | 0% | 0 | Common Stock | |
| VYNE Therapeutics Inc | Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2021 | 20,500 | 20,500 | - | - | Stock Options | |
| Agile Therapeutics Inc | Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 29,905 | 29,905 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 24,510 | 51,296 (0%) | 0% | 0 | Common Stock |